ArticleThe oncologist2022

Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study.

Giovanni Fucà et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.